Fraunhofer Institute for Toxicology and Experimental Medicine

Models of Lung Disease 2019: registration open, preliminary program available!

Innovative topics and impulses from translational lung research will be at the focus at the CRC Hannover on January 24 and 25.

more info

Australian researchers explored the German healthcare sector

On November 8, 2018, 16 Australian researchers visited Fraunhofer ITEM as part of the InnoTour 2018.

more info

Training course on in-silico toxicology

April 2-4, 2019 – introduction of three different in-silico approaches for estimation of human health toxicological endpoints, namely QSAR models, read-across, and the TTC concept.

more info

MDR – handicap for the innovation hotspot Germany

High-Performance Center Translational Biomedical Engineering is suggesting specific measures for a revision of the Medical Device Regulation.

more info

Chip-based cell analysis by chip cytometry

New technology at Fraunhofer ITEM enables sputum analysis by chip cytometry.

more info

Project EU-ToxRisk

Fraunhofer ITEM scientists will test new approach methodologies for animal-free toxicity testing and risk assessment

more info

A successful step in COPD research

The results of an innovative clinical study have proven a significantly positive effect on the heart function of COPD patients.

more info

Fraunhofer ITEM: News

Events / 10.12.2018

Models of Lung Disease

Registration is open and a preliminary program is available! Innovative topics and impulses from translational lung research will be at the focus at the CRC Hannover on January 24 and 25.

Press Release / 29.10.2018

Synergy-Boost

Aiming to prevent yet another infection of a replacement implant, Fraunhofer researchers have investigated how antibiotics and silver ions work synergistically. 

Press Release / 17.10.2018

Consequences of the MDR

High-Performance Center Translational Biomedical Engineering is suggesting specific measures for a revision of the Medical Device Regulation.

Press Release / 12.10.2018

InnoHealth Australia initiative

We look forward to 16 Australian researchers visiting Hannover on November 8 to get an insight into our applied research.  

 

Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0

Events

2.4.2019

Training course: In-silico toxicology

This training course will introduce the participants to three different in-silico approaches for estimation of human health toxicological endpoints, namely QSAR models, read-across, and the TTC (threshold of toxicological concern) concept. The application of in-silico approaches in ecotoxicology will not be addressed in this course.
Read more

24.1.2019

18th Fraunhofer Seminar "Models of Lung Disease"

On January 24 and 25, 2019, the 18th Fraunhofer Seminar "Models of Lung Disease" will take place at the CRC Hannover. Online registration is open and a preliminary program is available.
Read more

29.11.2018

FORUM Translational Medicine

Prof. Christoph Klein, Fraunhofer ITEM Division Director of Personalized Tumor Therapy, will give insights into the detection, characterization and monitoring of early and advanced systemic cancer at this year’s FORUM Translational Medicine in Würzburg.
Read more

22.11.2018

CAHMV 2018

Fraunhofer scientists Ariane Zwintscher and Franziska Schramm will represent Fraunhofer ITEM at the 4th Conference of Applied Hygiene, Microbiology and Virology in Hamburg on November 23, 2018.
Read more

Our services and expertise

 

Drug Development

From drug candidate to proof of concept

 

Chemical Safety and Assessment

From risk analysis towards safe products

 

Translational Biomedical Engineering

From idea to safe medical device

 

Personalized Tumor Therapy

From molecular analysis to personalized therapy

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of approximately 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.

More information about Fraunhofer ITEM